WPI 1119 (Mirtazapine 45 mg)
Pill imprint WPI 1119 has been identified as Mirtazapine 45 mg.
Mirtazapine is used in the treatment of depression; anxiety; insomnia; post traumatic stress disorder; hot flashes and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 1119 (Mirtazapine 45 mg)
- 45 mg
- 16.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
|NDC Code||Manufacturer / Repackager|
|16590-0155||Stat RX USA LLC (repackager)|
|58016-0282||Southwood Pharmaceuticals Inc (repackager)|
|63874-1155||Altura Pharmaceuticals Inc (repackager)|
|68258-7006||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
Mirtazapine is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...